← Open Payments lookup

ISABELLA MALINOWSKI: Open Payments

NPI 1992229538 · RIVERSIDE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$258 in 10 payments from 6 companies in 2025. Trend: 2023 $143 · 2024 $178 · 2025 $258

Food & beverage: $258
CompanyPaymentsAmount
Janssen Biotech, Inc.3$95
Takeda Pharmaceuticals U.S.A., Inc.2$53
Celltrion USA Inc.2$38
Madrigal Pharmaceuticals1$26
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$24
Novo Nordisk Inc1$21

Products named: TREMFYA, ENTYVIO, VEGZELMA, REZDIFFRA, XIFAXAN, Wegovy.

Industry payments across RI — which companies pay providers there.